SmartSeq s.r.l.

SmartSeq s.r.l. specializes in developing in vitro diagnostic (IVD) software tools designed for bioinformatics analysis. Their products include platforms like MicrobAT (for microbial genomics data processing), SmartVir (for viral sequence analysis), and Amplicon Suite (for automating amplicon sequencing workflows). These tools focus on streamlining data handling tasks such as format conversion, workflow automation, and database management to support next-generation sequencing (NGS) research.

SmartSeq s.r.l. is headquartered in Italy, which means its IVD devices are subject to EU regulatory requirements. Since their products fall under the IVD General class, they must comply with EU IVD Regulation (EU 2017/746) and are registered in the euDAMED database—a mandatory EU-wide registry for IVDs. This classification ensures their software meets essential performance criteria for diagnostic accuracy and safety before market placement.

Yes, SmartSeq’s IVD devices are listed in the euDAMED database. This registry is required under EU IVD Regulation to ensure transparency and traceability of all authorized diagnostic medical devices within the European Economic Area. Listing in euDAMED confirms the devices have undergone the necessary conformity assessment and meet regulatory standards before being made available to users.

SmartSeq’s devices are classified as IVD General class under EU regulations. This classification applies to low-to-moderate-risk diagnostic software that does not require invasive procedures or high-risk performance (e.g., no life-threatening decisions). For users, it means these tools undergo rigorous validation for accuracy, reliability, and safety but do not require the same stringent scrutiny as higher-risk IVDs (e.g., Class B, C, or D). The classification ensures they are suitable for research and clinical workflows where bioinformatics analysis is critical.